Piramal Pharma Ltd. - Research Center
543635 PPLPHARMA Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | |
|---|---|---|---|---|
| Sales | 4,390.11 | 3,443.22 | 3,094.95 | 2,938.81 |
| Operating profit | 617.92 | 97.53 | 397.30 | 618.93 |
| Interest | 107.10 | 115.87 | 53.55 | 4.71 |
| Gross profit | 712.88 | 322.73 | 567.34 | 812.19 |
| EPS (Rs) | 2.96 | 0.58 | 2.89 | 5.75 |
Annual
results in details
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | |
|---|---|---|---|---|
| Other income | 202.06 | 341.07 | 223.59 | 197.97 |
| Stock adjustment | -61.62 | 53.31 | -30.17 | 57.86 |
| Raw material | 1,545.55 | 1,166.48 | 1,003.68 | 986.70 |
| Power and fuel | - | - | - | - |
| Employee expenses | 613.93 | 548.50 | 425.30 | 395.15 |
| Excise | - | - | - | - |
| Admin and selling expenses | - | - | - | - |
| Research and development expenses | - | - | - | - |
| Expenses capitalised | - | - | - | - |
| Other expenses | 1,674.33 | 1,577.40 | 1,298.84 | 880.17 |
| Provisions made | - | - | - | - |
| Depreciation | 205.26 | 192.08 | 130.64 | 143.64 |
| Taxation | 116.40 | 54.19 | 81.18 | 115.28 |
| Net profit / loss | 391.22 | 69.50 | 343.05 | 571.50 |
| Extra ordinary item | - | -6.96 | -12.47 | 18.23 |
| Prior year adjustments | - | - | - | - |
| Equity capital | 1,322.95 | 1,193.32 | 1,185.91 | 994.60 |
| Equity dividend rate | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - |
| OPM (%) | 14.08 | 2.83 | 12.84 | 21.06 |
| GPM (%) | 15.52 | 8.53 | 17.10 | 25.89 |
| NPM (%) | 8.52 | 1.84 | 10.34 | 18.22 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis